Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT) in patients implanted with the Resolute Onyx Drug-Eluting Stent (DES)...
Antiplatelet and Anticoagulation Therapies
-
-
May 31, 2017 – The results from the first real-world, matched head-to-head study comparing all-cause healthcare costs and healthcare resource utilization (HCRU) among...
-
May 12, 2017 – A new study found that dementia rates increase with delays in starting anticoagulation treatment for...
-
March 21, 2017 — About 12 percent of patients undergoing aortic valve replacement developed non-symptomatic blood clots around the valve leaflets (known as subclinical leaflet thrombosis) that...
News | Antiplatelet and Anticoagulation Therapies | August 18, 2017
August 18, 2017 — Medtronic plc announced a global randomized...
News | Antiplatelet and Anticoagulation Therapies | August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI)...
News | Antiplatelet and Anticoagulation Therapies | August 03, 2017
August 3, 2017 — Abbott recently announced the first patient has been enrolled in a...
News | Antiplatelet and Anticoagulation Therapies | July 25, 2017
July 25, 2017 — A study by researchers at the University of Birmingham has shown that general practitioners (GPs)...
News | Point of Care Testing | July 17, 2017 | Dave Fornell
July 17, 2017 — Despite issues with point-of-care INR testing company Alere Inc., Abbott announced this week it is...
News | Antiplatelet and Anticoagulation Therapies | July 12, 2017
June 12, 2017 — Researchers have evaluated the long-term efficacy and safety of long-duration dual anti-platelet...
News | Antiplatelet and Anticoagulation Therapies | June 29, 2017
June 29, 2017 — Janssen Research & Development LLC announced the U.S. Food and Drug Administration (FDA)...
News | Antiplatelet and Anticoagulation Therapies | May 31, 2017
May 31, 2017 – The results from the first real-world, matched head-to-head study comparing all-cause healthcare...
Feature | Antiplatelet and Anticoagulation Therapies | May 12, 2017
May 12, 2017 – A new study found that dementia rates increase with delays in starting anticoagulation treatment for...
Point-of-care coagulation PT/INR testing with handheld devices can help improve outcomes with more convenient and frequent measurements to keep patients within the therapeutic range of anticoagulant agents.
Feature | Point of Care Testing | May 05, 2017 | Nicholas C. Vanderslice, Ph.D., and Arnol S. Rios
Point-of-care (POC) coagulation analyzers that measure prothrombin time/international normalized ratio (PT/INR) on...
Feature | Atrial Fibrillation | March 29, 2017
March 29, 2017 — Uninterrupted treatment with dabigatran (Pradaxa), a non-vitamin K,...
News | Antiplatelet and Anticoagulation Therapies | March 27, 2017
March 27, 2017 — Using genetic...
News | Antiplatelet and Anticoagulation Therapies | March 23, 2017
March 23, 2017 — Bleeding complications did not increase for patients with acute coronary syndrome treated with...
News | Antiplatelet and Anticoagulation Therapies | March 23, 2017
March 23, 2017 — In patients at elevated risk for a recurrence of potentially life- threatening blood clots, a low...
